GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics
Explore this paper's citation graph
Summary
GOLPH2 protein expression was significantly higher in prostate cancer glands compared with normal glands and upregulation was detected in 26 of 31 AMACR-negative prostate cancer cases, suggesting GolPH2 as an additional ancillary positive marker for tissue-based diagnosis of prostate cancer.
- Type
- article
- Published
- 2008-09-09
- Cited by
- 133
- References
- 43
- Access
- Open access
- OpenAlex
- https://openalex.org/W18781151
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:10769844
Keywords
Ethnic group, Folklore, Silence, Dream, State (computer science)
References
- Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression.
- Expression profiling reveals hepsin overexpression in prostate cancer.
- Molecular genetic profiling
- P504S: A New Molecular Marker for the Detection of Prostate Carcinoma
- Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.
- GP73, a novel Golgi-localized protein upregulated by viral infection
- Endosomal Trafficking and Proprotein Convertase Cleavage of cis Golgi Protein GP73 Produces Marker for Hepatocellular Carcinoma
- ONCOMINE: a cancer microarray database and integrated data-mining platform.
- Expression and Diagnostic Utility of Alpha-Methylacyl-CoA-Racemase (P504S) in Foamy Gland and Pseudohyperplastic Prostate Cancer
- The polycomb group protein EZH2 is involved in progression of prostate cancer
- Biomarkers for prostate cancer detection.
- Heterogeneous expression of α‐methylacyl‐CoA racemase in prostatic cancer correlates with Gleason score
- GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
- The prostate‐specific G‐protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to α‐methylacyl‐CoA racemase
- Disease- and Cell-Specific Expression of GP73 in Human Liver Disease
- alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
- Delineation of prognostic biomarkers in prostate cancer
- Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival
- p63 is a prostate basal cell marker and is required for prostate development.
- Integrative molecular concept modeling of prostate cancer progression
Cited by
- Quantification of protein expression in cells and cellular subcompartments on immunohistochemical sections using a computer supported image analysis system.
- Melanoma exhibiting cartilaginous differentiation
- Alpha-methylacyl-CoA racemase (AMACR) expression in epithelial ovarian cancer
- The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer
- Association of GOLPH2 expression with survival in non-small-cell lung cancer: clinical implications and biological validation.
- Representativity of TMA studies.
- Die hochgradige prostatische intraepitheliale Neoplasie
- Diagnostic and prognostic value of T-cell receptor gamma alternative reading frame protein (TARP) expression in prostate cancer.
- An investigation into tetraspanin CD151 as novel prognostic markers in poor outcome endometrial cancer
- Development of Novel Assays for Measuring Different Molecular Forms of Prostate Specific Antigen
- PSA ciągle najlepszy marker nowotworowy, modyfi kacje testu i nowe markery raka stercza
- Biomarker Discovery and Mechanistic Studies of Prostate Cancer Using Targeted Proteomic Approaches
- Analysis of novel targets in the pathobiology of prostate cancer
- Immunhistochemische Algorithmen in der Prostatadiagnostik
- Interleukin-6 and Oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73
- A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma
- Diagnostic and prognostic molecular biomarkers for prostate cancer
- The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer
- A Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside Potential
- Single Foci Prostate Cancer: Current Diagnosis and Management
Related papers
- Beyond the Godfather: Italian American Writers on the Real Italian American Experience
- "The Willingness to Speak": Diane di Prima and Italian American Feminist Body Politics
- Writing beyond History: An Anthology of Prose and Poetry
- A Tribute to Frances Smith Foster
- Interview between Maxine Hong Kingston and Sneja Gunew
- Recovery 2.0: Beginning the Collective Biographies of Women Project
- Saints, Sinners, Saviors: Strong Black Women in African American Literature (review)
- Voices of the Diaspora: Jewish Women Writing in Contemporary Europe (review)
- Interrogating the silences: Julia C. Collins, 19 th-century black readers and writers, and the Christian Recorder